<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01111799</url>
  </required_header>
  <id_info>
    <org_study_id>004608K</org_study_id>
    <nct_id>NCT01111799</nct_id>
  </id_info>
  <brief_title>Does Local Injury of the Endometrium Improve Controlled Ovarian Hyperstimulation (COH) + Intrauterine Insemination (IUI) Outcome?</brief_title>
  <official_title>Exploration of the Possibility That Local Injury of the Endometrium Has the Same Beneficial Effect on IUI Outcome as Demonstrated in IVF Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It was previously demonstrated in in vitro fertilization (IVF) patients that local injury of
      the endometrium during a spontaneous menstrual cycle that precedes IVF treatment doubled the
      rates of implantation and pregnancy. The hypothesis of our present study is that the
      endometrial injury procedure will have the same beneficial effect in patients undergoing
      controlled ovarian hyperstimulation (COH) combined with intrauterine insemination (IUI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to test our hypothesis, we will perform the simple procedure of local injury of the
      endometrium using a &quot;Pipelle&quot; biopsy catheter during the spontaneous menstrual cycle that
      precedes a COH + IUI treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Pregnancy rate</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live birth</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Infertility</condition>
  <condition>Implantation Failure</condition>
  <arm_group>
    <arm_group_label>Clomiphene citrate + IUI + endometrial biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clomiphene citrate + IUI + endometrial biopsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clomiphene citrate + IUI</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>gonadotrophines + IUI + endometrial biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gonadotrophines + IUI</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>natural cycle + IUI + endometrail biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>natural cycle + IUI</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endometrial biopsy</intervention_name>
    <description>two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.</description>
    <arm_group_label>Clomiphene citrate + IUI + endometrial biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endometrial biopsy</intervention_name>
    <description>two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.</description>
    <arm_group_label>gonadotrophines + IUI + endometrial biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>natural cycle + IUI + endometrial biopsy</intervention_name>
    <description>two endometrial biopsies will be taken with a PIPELLE catheter on days 12 and 21 of the spontaneous menstrual cycle that precedes the fertility treatment.</description>
    <arm_group_label>natural cycle + IUI + endometrail biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-38.

          -  infertility.

          -  patients undergoing IUI treatment.

          -  at least one failed IUI cycle.

        Exclusion Criteria:

          -  indication for IVF treatment.

          -  Known Pelvic inflammatory disease(PID).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuval Or, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clalit health service</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuval Or, MD</last_name>
    <phone>+97289445150</phone>
    <email>yuval_o@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leila Aliger, MD</last_name>
    <phone>+97289445150</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Remez women medical center</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuval Or, MD</last_name>
      <phone>+97289445150</phone>
      <email>yuval_o@clalit.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Ayelet Mokasey</last_name>
      <phone>+97589445150</phone>
      <email>ayeletmo@clalit.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Yuval Or, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril. 2003 Jun;79(6):1317-22.</citation>
    <PMID>12798877</PMID>
  </reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2010</study_first_submitted>
  <study_first_submitted_qc>April 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2010</study_first_posted>
  <last_update_submitted>March 15, 2012</last_update_submitted>
  <last_update_submitted_qc>March 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endometrial biopsy</keyword>
  <keyword>implantation</keyword>
  <keyword>uterine receptivity</keyword>
  <keyword>infertility</keyword>
  <keyword>controled ovarian hyperstimulation</keyword>
  <keyword>intra uterine insemination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

